Boehringer Ingelheim Pharmaceuticals Inc. has appointed Brian Hilberdink as President, U.S. Human Pharma. Hilberdink’s arrival comes at a pivotal time for the company, as Boehringer grows its existing portfolio and accelerates its preparation for the launch of several new assets in its pipeline. He will play a pivotal role in fostering Boehringer’s culture and driving meaningful impact for patients. Experience Hilberdink is an accomplished global leader with over 25 years of exper...